± 22.32 μmol/ml RBCs) which was held after a month, but it was not statistically significant. Activity of SOD and CAT, before and after HBOT, did not changed significantly.
. While several studies implicate nitric oxide as an important mediator of disease in SLE 6, 7 , there is a lack of data revealing the association between level of urine nitrite and citrulline levels, as surrogate markers of nitrogen monooxide (NO) production, among patients with systemic lupus erythematosus and disease activity 8 . Also, previous data suggested that lipid peroxidation could be a risk factor for endothelial dysfunction in some autoimmune diseases 9 .
Hyperbaric oxygen therapy (HBOT) is a treatment modality in which a person breathes 100% O 2 intermittently while exposed to increased atmospheric pressure, greater than 1 atmosphere, usually 2 to 2.5 atmospheres absolute (ATA) 10 . Primary mechanisms of action include hyperoxygenation and a decrease in bubble size, or vasoconstriction, angiogenesis, fibroblast proliferation, oxidative leukocyte degradation, toxin inhibition and antibiotic synergy 11, 12 .Hyperbaric oxygen may be used as the primary therapy intervention in some conditions, such as carbon monoxide poisoning, decompression sickness and arterial gas embolism, arterial insufficiencies, cardiovascular diseases, osteomyelitis and as an adjunctive therapy for wound healing [13] [14] [15] . HBOT has shown beneficial effects in hypoxic diabetic ulcers that result in severe wound-healing problems and osteoradionecrosis, and is frequently used for necrotic soft tissues and bone that fails to heal. HBOT also induces significant angiogenesis, which in one study was measurable after eight HBOT sessions. Previous clinical studies revealed that vasculitis skin ulcers in patient suffering from SLE has been treated successfully with HBOT [16] [17] [18] . There are not many studies that examined effects of HBO treatment on redox homeostasis and inflammation in patients with SLE.
Given the fact that HBOT can modify oxidation-reduction reactions, the aim of our study is to establish an influence of hyperbaric oxygenation on oxidative stress parameters and antioxidant enzymes in patients with SLE.
Participants and Methods
This prospective study included 18 females with SLE, treated with hyperbaric oxygenation therapy once a day for 60 minutes (total 10 days) with average partial oxygen pressure of 2.2 ATA, in combination with appropriate therapy for SLE. The study protocol was approved by the Institutional Ethics Committee (Faculty of Medicine of the Military Medical Academy, University of Defence Studies, Belgrade, Serbia) and the study was conducted in accordance with the Declaration of Helsinki. All the participants were informed about the research protocol before giving their written consent to participate in the study.
All patients were admitted to Military Medical Academy, Belgrade, Serbia from October 2011 to December 2014, providing that they fulfilled inclusion criteria: a diagnosis of SLE.
In order to define severity of the disease course in this study the original 1997 ACR classification of SLE was used 18, 19 . All participants were in similar stage of disease, in remission (SLEDAI Score 0,30 ± 0,47), at the beginning of study. The exclusion criteria were: pregnant women with SLE, patients with urinary infection (positive urine culture), with renal insufficiency-creatinine clearance <60 ml/min, the presence of malignancy, patients with any other ongoing inflammatory process, or under 18 years of age. Patients who were on immunosuppressive therapy such as mycophenolate mofetil, cyclophosphamide and other cytotoxic agents, were excluded. The only therapy, that the patients have taken, was the corticosteroids-the maintenance dose of 5mg.
All patients with any contraindication for HBOT were also excluded. All participants were non-smokers and did not take any antioxidant dietary supplement for 1 month before the study. Before beginning the HBOT, all participants passed a standard medical and physical revision at the hospital. During the study period there were no eliminated patients.
Hyperbaric oxygen therapy (HBOT)
HBOT was performed at The Center for Hyperbaric Medicine, Military Medical Academy in Belgrade, Serbia. HBOT treatment consisted of 10 sessions (1 session a day/5 days a week) in a multiplace (10-person) hyperbaric chamber. In total 60 min of 100% medical oxygen was administered to patients under increased pressure of 2.2 atmospheres absolute (ATA) during a 70-min hyperbaric session. At this pressure, 100% oxygen was delivered via an oronasal mask in two episodes of 30 min, each interrupted by 5 min of air breathing. During pressure changes, great care was taken to avoid barotraumas, particularly of the middle ear, which is the most common side-effect of a hyperbaric treatment. All patients tolerated the treatment well without any complications.
Biochemical analysis
Samples for biochemical analysis were collected three times: before HBOT (initial values), after 10 days of HBOT(2 hours after last HBOT session) and after 1 month. The 
Hydrogen peroxide determination (H 2 O 2 )
The protocol for measurement of hydrogen peroxide (H 2 O 2 ) is based on oxidation of phenol red in the presence of horseradish peroxidase 21 rpm. After pouring off the supernatant, 220 μl K 2 CO 3 was added. Nitrites were measured at 550 nm. Distilled water was used as a blank probe.
Determination of concentration of thiobarbituric acid reactive substances (TBARS)
The degree of lipid peroxidation in urine was estimated by measuring concentration of TBARS using 1 % TBA (thiobarbituric acid) in 0.05 NaOH, incubated with urine at 100 °C for 15 min and read at 530 nm. Distilled water was used as a blank probe. TBA extract was obtained by combining 0.8 ml urine and 0.4 ml trichloro-acetic acid (TCA), than samples were put on ice for 10 min, and centrifuged for 15 min at 6,000 rpm. This method was described previously 23 .
Preparation of hemolysate
Blood samples were taken from an antecubital vein into vacutainer test tube containing sodium citrate anticoagulant. Blood was centrifuged to separate plasma and red blood cells (RBCs). Isolated RBCs were washed 3 times with 3 vol. of ice cold 0.9 mmol/l NaCl. Blood samples were stored immediately and kept for further analyses 24 .
Determination of antioxidant enzymes catalase (CAT) and superoxide dismutase (SOD)
Hemolysates containing about 50 g Hb/l prepared according to McCord and SOD activity was determined by the epinephrine method of Misra and Fridovich 26 and it was expressed in U/gHb x 1000. A hundred μl lysate and 1 ml carbonate buffer were mixed, and then 100 μl of epinephrine was added. Detection was performed at 470 nm.
Determination of reduced glutathione (GSH)
Level of reduced glutathione (GSH) was determined spectrophotometrically, and it is based on GSH oxidation via 5,5-dithiobis-6,2-nitrobenzoic acid. GSH extract was obtained by combining 0.1 ml 0.1 % EDTA, 400 μl haemolysate, and 750 μl precipitation solution (containing 1.67 g metaphosphoric acid, 0.2 g EDTA, 30 g NaCl, and filled with distilled water until 100 ml; the solution is stable for 3 weeks at +4C°). After mixing in the vortex machine and extraction on cold ice (15 min), it was centrifuged on 4000 rpm (10 min). Distilled water was used as a blank probe. Measuring was performed at 420 nm. The concentration is expressed as micromoles per milliliter of red blood cells (RBCs). 25, 27 
Statistical analyzes
In case of continuous data, variables were presented as mean value ± standard (Table 1) .
Levels of Superoxide anion radical (O 2 -)
We noticed statistically significant decreased (p<0.05) levels of superoxide anion radical (O 2 -) after 30 days HBOT compared to initial values of this parameter, and significantly decreased values after 10 days of HBOT compared to initial values (11.92 ± 6.86, 8.26 ± 13.6, 8.39±4.94 nmol/ml) ( Fig. 1) .
Levels of Nitrites (NO 2 -)
Levels of nitrites (NO 2 -) before and after HBOT therapy were similar (2.72±0.16, 2.77±0.29, 2.76±0.20 nmol/ml). We found that this parameter was not significantly affected with HBOT when comparing initial values to values after 10 days of HBOT and after one month (Fig. 2) .
Levels of Hydrogen peroxide (H 2 O 2 )
During the observed period of HBOT, there were no statistically significant changes of H 2 O 2 levels when compared the initial values, values after 10days and after one month of HBOT. This parameter was not changed in the group during the study (1.52 ±0.08, 1.51± 0.07, 1.54 ±0.17 nmol/ml) ( Fig. 3) .
Concentration of TBARS
Among the examined groups, TBARS concentration was not significantly altered after HBOT treatment and after a month (1.01 ±0.11; 1.09± 0.11; 1.05±0.96 µmol/ml) ( Fig.   4 ).
Activity of superoxide dismutase (SOD)
In the study group, we noticed a decreased activity of SOD after HBOT when compared initial value to value after 10 days of therapy (27.58±8.86 to 19.47±10.63 after HBOT). However, a month after, values were similar to those from the beginning of the study protocol and the acitivity was 27.11±28.26. Those changes were without statistical significance ( Fig. 5 ).
Level of reduced glutathione (GSH)
Level of reduced glutathione (GSH) was not statistically significant increased in our group (initially 66.34±16.31 to 79.43±36.77 after HBOT treatment). However, a month after values were similar to those from the beginning of the study protocol and the activity was 69.72 ± 22.32 (Fig. 6 ).
Activity of catalase (CAT)
We observed a decrease in the activity of catalase (CAT) after 10 days of HBOT compared to the initial value (5.44 ± 3.55 to 4.77 ±2.93), and it continued to decrease, so after a month it was lower than before HBOT and after 10 days of HBOT (3.82 ± 2.49).
However those differences were not statistically significant (Fig. 7) .
Discussion
This study was designed in the field of physiology research of hyperbaric oxygenation with special emphasis on potential systemic effects of disturbed redox balance, induced by systemic disease before and after the application of oxygen. Actually, hyperbaric oxygen therapy (HBOT) leads to an increase in the amount of dissolved oxygen in the plasma, creating a diffusion gradient which facilitates the transition of oxygen from the capillaries to the ischemic tissues 17 Our study included patients with SLE in whom the disease was in remission, which was maintained before and after HBOT was performed. Comparing laboratory parameters (CRP, hemoglobin, creatinine, albumin, complement C3, ANA) before and after the performed therapy, as well as after a month, we did not notice statistically significant differences in values. We examined the effects of 10 session of HBOT on parameters of redox balance in patients with SLE . We found statistically significant decreased levels of O 2 after HBOT, which were held after 30 days. There is a concern that HBOT might increase oxidative stress via the production of reactive oxygen species, however oxidative stress appears to be less of a concern at hyperbaric pressures under 2.0 ATA 33 . Patients in our study were exposed to the higher pressure such as 2.2 ATA and we revealed the beneficial effects of hyperbaric oxygen on O 2 levels. On the other hand, other pro-oxidants, such as NO 2 -, TBARS and H 2 O 2 were not affected by HBOT. In order to validate our results, we excluded all patients with renal disease or urinary infection, because oxidative stress parameters may have not been removed from plasma because of insufficient excretion and may continue to rediffuse in circulation [30] [31] [32] [33] . So, because of this fact, we could not be sure in unchanged levels of oxidative markers.
Literature data regarding the effects of HBOT on SLE treatment is limited, and it is hard to compare our results to the others due to the fact that available researches were mostly focused on the effects of HBOT on ulcers healing. One of a few studies which examined the effects of HBOT in a SLE patient was a case report conducted by Olivieri et al 17 . They described a SLE patient with a case of refractory vasculitic ulcer responding to hyperbaric oxygen (HBO), which was used in combination with immunosuppressive therapy. Jou and coworkers 35 reported their experience with the use of hyperbaric oxygen for the treatment of intractable hemorrhagic cystitis in an SLE patient treated with cyclophosphamide. They concluded that this treatment was very successful, with no recurrent hematuria after hyperbaric oxygen therapy during 6 months 35 . S. Efrat et al 16 reported that HBOT may serve as an effective safe treatment for patients with vasculitis having nonhealing skin ulcers, which is in agreement with the results of previously mentioned authors and with ours regarding safety of HBOT. Increase in tissue oxygenation appeared to be one of the major components responsible for the high cure rates in patients with ulcers 16, 17 .
In order to complete our picture about influence of HBOT on redox status, we examined activity of antioxidant enzyme system. GSH is an important endogenous antioxidant and prime scavenger of free radicals in cells. One of the body's most powerful natural antioxidant enzymes are superoxide dismutase and catalase. Superoxide dismutase, essential to catalyze the dismutation of superoxide, has been shown to protect cells from oxygen free radicals. Exposure to ROS from a variety of sources led to develop a series of defence mechanisms to neutralize these species and so protect cells against their toxic effects and that protection is achieved mainly by enzymatic antioxidants such as catalase.
Some of the research concludes that hyperbaric oxygen treatment below 2.0 ATA can increase the activity of antioxidant enzymes including SOD, reduced glutathione and catalase [36] [37] [38] [39] [40] .
Regarding component of antioxidant defense including SOD, GSH, CAT we observed that levels of GSH were higher (but without statistical significance) after 10 days exposed to hyperbaric oxygen treatment and month later too.
We believe that these beneficial results in regard to levels ofO 2 and GSH after
HBOT implyto possibility that the study with lager number of patients or changes of number of treatments could have results which would be statistically significant for these parameters. That refers on results noticed for SOD and CAT.
Activities of SOD and CAT were affected by HBOT but not statistically significantly. We have noticed that activity of SOD decreased after 10 days, but returned to the initial level after 30 days, and level of CAT decreased after a month compared to the initial value and value after 10 days of HBOT. However, these changes were not statistically significant. Considering that differences in the activity of SOD and CAT between peroxide initial level and level after HBOT were insignificant, we have not observed any significant influence on pro-oxidants such as hydrogen, showed insignificant difference.
We believe that the smaller number of patients participated in our study has influenced on our results. The assumption is that the future studies with different design (larger number of patients, more treatments, additional analysis etc.) could clarify the fact that we have not got correlation between decreased level of O 2 -(statistically significant in our study) and increased values of antioxidant protection parameters(GSH not statistically significant in our study).
We decided to treat SLE patients with HBOT not only because it improves the oxygenation of ischemic tissues and exerts beneficial effects on vascular inflammatory response by regulating the chemotaxis of leukocytes, but also because it facilitates the healing process of infected wounds promoting the deposition of collagen, angiogenesis, epithelialization and facilitating the oxygen-dependent killing by leukocytes [16] [17] [18] . Previous studies suggested that vasculitis skin ulcers in patient suffering from SLE had been treated successfully with HBOT 17 .
Given the fact that HBOT can modify oxidation-reduction reactions and because of mentioned beneficial effects of HBOT in different tissues in patients with SLE, this protocol of therapy can be one of the possibility.
Conclusion
Our results highlighted some of the beneficial effects of hyperbaric oxygen treatment on redox balance among patients suffering from systemic lupus erythematosus.
However, management of systemic lupus erythematosus (SLE) is complex and more research is required to establish the complete mechanism by which HBOT can modify oxidation-reduction reactions in patients with SLE so it can become a additional potential therapeutic strategy in treatment of SLE. There was no significant difference before and after HBOT. Received on January 10, 2017.
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